MEDICE Health Family establishes strategic partnership with digital health company Selfapy


MEDICE is a new investor and strategic partner of the Berlin-based company Selfapy, which offers effective help in the form of digital health applications to people with mental illness. A financing round of €7 million was notarized in Berlin on December 23, 2022. The deal was led by MEDICE.

7 Million euros for further growth in Germany and Europe

"The funding round is an important milestone and a confirmation of the confidence in the success of Selfapy," said a delighted Nora Blum, co-CEO and founder of Selfapy. The capital provided will be used to develop further digital health applications for various mental health disorders and to grow in the German market. Another part of the capital will be used to enter the market in other European countries: "We see a great potential of digital therapies in the field of mental disorders both in Germany and internationally. With five completed RCT studies and a broad user base in Germany, we are well on our way to expanding our offering to other indications and into other markets," emphasized Adham Kassab, Co-CEO of Selfapy.

"The strong development of Selfapy over the past few years speaks for itself. Digital health applications will keep gaining importance in the coming years. We continue to see a lot of growth potential here and are pleased to accompany Selfapy on this path," said Dr. Richard Ammer, CEO of MEDICE.

MEDICE expands its medigital® business with Selfapy to include new digital health applications for people with mental health conditions.

Digital health solutions that enable therapists to individualize and improve patient management even with non-pharmacological intervention options are a key pillar of the MEDICE Health Family's strategic direction.

"Under the medigital® brand, we are already decisively developing therapy efficiency in the field of child psychiatry through integrated digital health applications with our eyelevel business," said Dr. Katja Pütter-Ammer, managing partner of MEDICE. "The new cooperation with Selfapy strengthens our strategic approach while opening up additional indication areas." MEDICE's strategic investment will flow into the development of further digital health applications as well as into the conduct of further clinical studies.